Gloria Vega
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome (NCT03004001) | Gloria Vega | 2017-01-01 |
Track Gloria Vega automatically
Every clearance here is in the API, with alerts when new ones post.